373 related articles for article (PubMed ID: 17882646)
1. Renaming "chemobrain".
Hurria A; Somlo G; Ahles T
Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
[TBL] [Abstract][Full Text] [Related]
2. Cognitive side-effects of adjuvant treatments.
Burstein HJ
Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
Reid-Arndt SA
Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
5. Chemobrain: is systemic chemotherapy neurotoxic?
Taillibert S; Voillery D; Bernard-Marty C
Curr Opin Oncol; 2007 Nov; 19(6):623-7. PubMed ID: 17906463
[TBL] [Abstract][Full Text] [Related]
6. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
7. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive changes in cancer survivors.
Correa DD; Ahles TA
Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
[TBL] [Abstract][Full Text] [Related]
10. [Cognitive impairments and breast cancer: a critical review of the literature].
Vandenbossche S; Fery P; Razavi D
Bull Cancer; 2009 Feb; 96(2):239-48. PubMed ID: 19258230
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
Dutta V
J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
[TBL] [Abstract][Full Text] [Related]
12. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
Myers JS; Pierce J; Pazdernik T
Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
[TBL] [Abstract][Full Text] [Related]
14. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
15. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
Alvarez J; Meyer FL; Granoff DL; Lundy A
Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
[TBL] [Abstract][Full Text] [Related]
16. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
Tannock IF; Ahles TA; Ganz PA; Van Dam FS
J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
[TBL] [Abstract][Full Text] [Related]
19. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy?
Player L; Mackenzie L; Willis K; Loh SY
Aust Occup Ther J; 2014 Aug; 61(4):230-40. PubMed ID: 24499127
[TBL] [Abstract][Full Text] [Related]
20. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
